Cart 0



Columbia University

211 Low Memorial Library
535 West 116th Street
New York, New York 10027

Immuno Technologies, Inc. entered into a research agreement with Columbia University in May of 2014, working with researchers in the Fu Foundation School of Engineering and Applied Sciences to perform work to determine conditions for binding novel antigens to solid, microfluidic surfaces. The funding for this point-of-care technology, which involves the combination of well-selected antigens with rapid, multiplex assays, will improve the diagnosis and management of Lyme disease.

University of Tennessee Health Science Center

The Department of Microbiology, Immunology and Biochemistry
858 Madison Avenue
G01 Molecular Sciences Building
Memphis, TN 38163

Immuno Technologies, Inc. entered a contract with University of Tennessee Health Science Center in July of 2014, and has carried on the partnership since. Major projects within the labs involve the development of reservoir targeted vaccines against spirochetal diseases, specifically Lyme disease and Leptospirosis.   



OPKO Diagnostics, LLC

4 Constitution Way
Woburn, MA 0801

Immuno Technologies, Inc. partnered with Opko Diagnostics, LLC, a pharmaceutical and diagnostic company. The partnership focused on the development of a rapid diagnostic test for Lyme Disease using Opko’s Claros 1 in office diagnostic system.

US Biologic, Inc.

20 S Dudley St
Memphis, TN 38103

Immuno Technologies, Inc. partnered with US Biologic, a biotechnology company focused on disease prevention using a proprietary oral-delivery system.